Here is a look on to Pfizer Inc. (NYSE:PFE) dividend, that what are the factor that may affect its dividend may in positive way or negative way.

As the company belongs to Health care sector so it has many benefits from the industry that make PFE attractive for dividend investors. So in this scenario being a pharmaceutical high costs didn’t affect this sector due to reason gradually increasing unhealthy society adopted health care product at any cost that is a key reason health care spending will continue to grow.

When we examine the Payout ratios Pfizer Inc it is evident that it is higher then over all industry average. The payout ratio of the company is 45.5 % as compare to industry average 36.8 % in 2012 as compare to 2011 33.6 % and 28.2% respectively. These value show how the company’s is payback a handsome amount t its shareholders, which will encourage other investors to spend in the company, this would suggesting additional ability for future dividend hikes.

The company EV/EBITDA is 7.7 while the industry average for the same if 9.2, while Pfizer Inc. price to earnings P/E is 12.4 in contrast to industrial average 13.2.

But that is not all contributing to the company dividend as positive; rather there are some negative impacts too on the company like Lipitor’s patent cliff. No doubt its payout ratio increase from 2011 to 2012, but it still under 50%, and is concerning to investors.

Shares of Pfizer Inc. (NYSE:PFE) in last trading session closed at $28.02 by falling -0.32% with traded volume of 63.16 million shares which is up the average volume of 29.61 million shares.